Compositions and methods are provided for incorporating processed oils with high monoacylglyceride (MAG) content into products and food products. Methods are specifically provided for generating high MAG content processed oils.

The present invention relates to a method for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents, to the solubilisate produced by this method and respective uses as a dietary supplement or pharmaceutical dosage form. A phosphatidylcholine-based solubilization method is disclosed.

A sugar-free soluble tea extract tablet and a method for preparing it that includes the steps of providing a sweetener blend, a natural binder, and a tea extract, in a proportion of five grams of sweater blend and one gram of natural binder for every one gram of tea extract. Then, heating the sweetener blend to melt into a liquid at a temperature ranged between 100 to 300 degrees Celsius, adding the tea extract and the natural binder to the melted sweetener blend to form a mixture, stirring the mixture thoroughly and pouring it into molds for cooling. The sweetener blend includes Erythritol and Monkfruit or stevia sweetener, and the natural binder is an organic gum fiber blend such as organic guar gum, organic gum arabic, organic agave fiber, organic rice hulls, or organic agave syrup.

Various ingredients and compositions are prepared from Stevia rebaudiana Bertoni plant. The compositions can be used as bulking agents, and sweeteners in foods, beverages, cosmetics and pharmaceuticals.

Various ingredients and compositions are prepared from Stevia rebaudiana Bertoni plant. The compositions can be used as bulking agents, and sweeteners in foods, beverages, cosmetics and pharmaceuticals.

A composition for krill-based protein supplement that provides a user with the necessary protein supply to repair and build muscle. The composition allows the body of a user to easily process and absorb the protein and nutrients as well. The composition includes a quantity of krill powder, a quantity of whey protein, and a quantity of digestive enzymes. The combination of the quantity of krill powder and the quantity of whey protein overcomes the natural response of blood thinning due to the quantity of krill powder and allows the composition to be consumed safely. The composition further includes a quantity of cocoa powder, a quantity of silicon dioxide, a quantity of stevia, and a quantity of sweetly stevia so that the composition may be thoroughly mixed with a beverage and still taste good.

A method for controlling foam comprising providing food composition comprising a foam control agent and a foodstuff, the foam control agent comprising a Mono glycidyl ether adduct or a Diglycidyl ether adduct. A composition useful for foam control comprising a mono glycidyl ether adduct, a diglycidyl ether adduct or combination thereof.

Embodiments of the invention are related generally to compositions comprising Co-Q10, a source of omega-3 fatty acids, and vitamin D, and methods of making thereof. In particular, the invention relates to stable compositions comprising Co-Q10, krill oil, vitamin D, and an antioxidant suitable for use as dietary supplements, and methods of making thereof. The compositions may further comprise an emulsifier to impart stability to the compositions.

An antibiotic composition containing a wasp extract as an active ingredient, and more particularly, a pharmaceutical composition and a health functional food for preventing, ameliorating or treating diabetes by α-amylase inhibition and α-glucosidase inhibition, which contain a wasp extract as an active ingredient. The wasp extract exhibits strong antidiabetic activity by effectively inhibiting amylase, has no human erythrocyte hemolytic activity, has excellent heat stability, and the activity thereof is not lost even under an acidic condition of pH 2 and in plasma. The wasp extract of the present disclosure may be processed into various forms such as extracts, powders, pills or tablets, which can be taken at all times.

Disclosed are a novel strain of Bacillus amyloliquefaciens, a method of producing fermented grains using the strain, fermented grains produced using the strain, and a composition for thrombolysis; digestion improvement; prophylaxis, amelioration or treatment of bowel inflammation, serous membrane weakening or intestinal injury; or antioxidation, comprising the fermented grains.